Logo image of CI

THE CIGNA GROUP (CI) Stock Fundamental Analysis

NYSE:CI - New York Stock Exchange, Inc. - US1255231003 - Common Stock - Currency: USD

296.04  +3.87 (+1.32%)

Fundamental Rating

5

CI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. CI has a medium profitability rating, but doesn't score so well on its financial health evaluation. A decent growth rate in combination with a cheap valuation! Better keep an eye on CI. CI also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CI was profitable.
CI had a positive operating cash flow in the past year.
In the past 5 years CI has always been profitable.
CI had a positive operating cash flow in each of the past 5 years.
CI Yearly Net Income VS EBIT VS OCF VS FCFCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

CI has a Return On Assets of 3.34%. This is in the better half of the industry: CI outperforms 66.99% of its industry peers.
With an excellent Return On Equity value of 12.51%, CI belongs to the best of the industry, outperforming 80.58% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 8.54%, CI is in the better half of the industry, outperforming 76.70% of the companies in the same industry.
CI had an Average Return On Invested Capital over the past 3 years of 7.53%. This is below the industry average of 9.72%.
The 3 year average ROIC (7.53%) for CI is below the current ROIC(8.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.34%
ROE 12.51%
ROIC 8.54%
ROA(3y)3.41%
ROA(5y)3.82%
ROE(3y)11.49%
ROE(5y)12.53%
ROIC(3y)7.53%
ROIC(5y)6.93%
CI Yearly ROA, ROE, ROICCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 1.97%, CI is in the better half of the industry, outperforming 60.19% of the companies in the same industry.
CI's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 3.75%, CI is in line with its industry, outperforming 56.31% of the companies in the same industry.
In the last couple of years the Operating Margin of CI has declined.
The Gross Margin of CI (10.25%) is worse than 75.73% of its industry peers.
In the last couple of years the Gross Margin of CI has declined.
Industry RankSector Rank
OM 3.75%
PM (TTM) 1.97%
GM 10.25%
OM growth 3Y-6.1%
OM growth 5Y-7.49%
PM growth 3Y-23.32%
PM growth 5Y-16%
GM growth 3Y-7.3%
GM growth 5Y-8.44%
CI Yearly Profit, Operating, Gross MarginsCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CI is destroying value.
The number of shares outstanding for CI has been reduced compared to 1 year ago.
The number of shares outstanding for CI has been reduced compared to 5 years ago.
The debt/assets ratio for CI is higher compared to a year ago.
CI Yearly Shares OutstandingCI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CI Yearly Total Debt VS Total AssetsCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

An Altman-Z score of 2.64 indicates that CI is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.64, CI perfoms like the industry average, outperforming 59.22% of the companies in the same industry.
CI has a debt to FCF ratio of 5.07. This is a neutral value as CI would need 5.07 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 5.07, CI is doing good in the industry, outperforming 65.05% of the companies in the same industry.
A Debt/Equity ratio of 0.66 indicates that CI is somewhat dependend on debt financing.
CI has a Debt to Equity ratio of 0.66. This is comparable to the rest of the industry: CI outperforms 53.40% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 5.07
Altman-Z 2.64
ROIC/WACC0.97
WACC8.78%
CI Yearly LT Debt VS Equity VS FCFCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

A Current Ratio of 0.78 indicates that CI may have some problems paying its short term obligations.
CI has a worse Current ratio (0.78) than 82.52% of its industry peers.
A Quick Ratio of 0.69 indicates that CI may have some problems paying its short term obligations.
With a Quick ratio value of 0.69, CI is not doing good in the industry: 80.58% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.69
CI Yearly Current Assets VS Current LiabilitesCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

5

3. Growth

3.1 Past

CI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.54%.
Measured over the past years, CI shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.05% on average per year.
The Revenue has grown by 23.96% in the past year. This is a very strong growth!
Measured over the past years, CI shows a quite strong growth in Revenue. The Revenue has been growing by 9.98% on average per year.
EPS 1Y (TTM)5.54%
EPS 3Y10.13%
EPS 5Y10.05%
EPS Q2Q%4.17%
Revenue 1Y (TTM)23.96%
Revenue growth 3Y12.39%
Revenue growth 5Y9.98%
Sales Q2Q%14.4%

3.2 Future

CI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.32% yearly.
CI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.63% yearly.
EPS Next Y11.83%
EPS Next 2Y11.63%
EPS Next 3Y11.58%
EPS Next 5Y11.32%
Revenue Next Year5.37%
Revenue Next 2Y4.76%
Revenue Next 3Y5.08%
Revenue Next 5Y5.63%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CI Yearly Revenue VS EstimatesCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 100B 200B 300B
CI Yearly EPS VS EstimatesCI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20 40 60

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.72 indicates a reasonable valuation of CI.
85.44% of the companies in the same industry are more expensive than CI, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CI to the average of the S&P500 Index (27.91), we can say CI is valued rather cheaply.
With a Price/Forward Earnings ratio of 8.69, the valuation of CI can be described as very reasonable.
Based on the Price/Forward Earnings ratio, CI is valued cheaper than 86.41% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CI to the average of the S&P500 Index (37.11), we can say CI is valued rather cheaply.
Industry RankSector Rank
PE 10.72
Fwd PE 8.69
CI Price Earnings VS Forward Price EarningsCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CI is valued a bit cheaper than the industry average as 76.70% of the companies are valued more expensively.
75.73% of the companies in the same industry are more expensive than CI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.16
EV/EBITDA 8.03
CI Per share dataCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400 600 800

4.3 Compensation for Growth

CI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.91
PEG (5Y)1.07
EPS Next 2Y11.63%
EPS Next 3Y11.58%

7

5. Dividend

5.1 Amount

CI has a Yearly Dividend Yield of 1.98%.
CI's Dividend Yield is rather good when compared to the industry average which is at 2.61. CI pays more dividend than 90.29% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, CI has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.98%

5.2 History

On average, the dividend of CI grows each year by 169.26%, which is quite nice.
CI has paid a dividend for at least 10 years, which is a reliable track record.
CI has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)169.26%
Div Incr Years4
Div Non Decr Years19
CI Yearly Dividends per shareCI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

31.35% of the earnings are spent on dividend by CI. This is a low number and sustainable payout ratio.
CI's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP31.35%
EPS Next 2Y11.63%
EPS Next 3Y11.58%
CI Yearly Income VS Free CF VS DividendCI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
CI Dividend Payout.CI Dividend Payout, showing the Payout Ratio.CI Dividend Payout.PayoutRetained Earnings

THE CIGNA GROUP

NYSE:CI (7/30/2025, 3:25:10 PM)

296.04

+3.87 (+1.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners91.81%
Inst Owner Change0.6%
Ins Owners0.34%
Ins Owner Change3.45%
Market Cap79.08B
Analysts81.18
Price Target383.04 (29.39%)
Short Float %1.1%
Short Ratio1.65
Dividend
Industry RankSector Rank
Dividend Yield 1.98%
Yearly Dividend5.53
Dividend Growth(5Y)169.26%
DP31.35%
Div Incr Years4
Div Non Decr Years19
Ex-Date09-04 2025-09-04 (1.51)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.28%
Min EPS beat(2)-17.61%
Max EPS beat(2)3.05%
EPS beat(4)3
Avg EPS beat(4)-2.88%
Min EPS beat(4)-17.61%
Max EPS beat(4)3.05%
EPS beat(8)5
Avg EPS beat(8)-1.54%
EPS beat(12)8
Avg EPS beat(12)0.01%
EPS beat(16)11
Avg EPS beat(16)1.25%
Revenue beat(2)2
Avg Revenue beat(2)2.95%
Min Revenue beat(2)0.59%
Max Revenue beat(2)5.31%
Revenue beat(4)4
Avg Revenue beat(4)2.71%
Min Revenue beat(4)0.59%
Max Revenue beat(4)5.31%
Revenue beat(8)5
Avg Revenue beat(8)1.17%
Revenue beat(12)5
Avg Revenue beat(12)0.25%
Revenue beat(16)8
Avg Revenue beat(16)0.25%
PT rev (1m)0.01%
PT rev (3m)4.36%
EPS NQ rev (1m)0.31%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2%
Valuation
Industry RankSector Rank
PE 10.72
Fwd PE 8.69
P/S 0.31
P/FCF 13.16
P/OCF 10.63
P/B 1.97
P/tB N/A
EV/EBITDA 8.03
EPS(TTM)27.61
EY9.33%
EPS(NY)34.07
Fwd EY11.51%
FCF(TTM)22.5
FCFY7.6%
OCF(TTM)27.86
OCFY9.41%
SpS955.93
BVpS150.58
TBVpS-124.25
PEG (NY)0.91
PEG (5Y)1.07
Profitability
Industry RankSector Rank
ROA 3.34%
ROE 12.51%
ROCE 10.1%
ROIC 8.54%
ROICexc 9.44%
ROICexgc 65.2%
OM 3.75%
PM (TTM) 1.97%
GM 10.25%
FCFM 2.35%
ROA(3y)3.41%
ROA(5y)3.82%
ROE(3y)11.49%
ROE(5y)12.53%
ROIC(3y)7.53%
ROIC(5y)6.93%
ROICexc(3y)8.17%
ROICexc(5y)7.51%
ROICexgc(3y)41.92%
ROICexgc(5y)35.13%
ROCE(3y)8.97%
ROCE(5y)8.27%
ROICexcg growth 3Y24.32%
ROICexcg growth 5Y14.18%
ROICexc growth 3Y11.69%
ROICexc growth 5Y5.98%
OM growth 3Y-6.1%
OM growth 5Y-7.49%
PM growth 3Y-23.32%
PM growth 5Y-16%
GM growth 3Y-7.3%
GM growth 5Y-8.44%
F-Score7
Asset Turnover1.7
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 5.07
Debt/EBITDA 2.15
Cap/Depr 52.92%
Cap/Sales 0.56%
Interest Coverage 6.92
Cash Conversion 60.54%
Profit Quality 119.39%
Current Ratio 0.78
Quick Ratio 0.69
Altman-Z 2.64
F-Score7
WACC8.78%
ROIC/WACC0.97
Cap/Depr(3y)48.86%
Cap/Depr(5y)45.02%
Cap/Sales(3y)0.7%
Cap/Sales(5y)0.69%
Profit Quality(3y)189.84%
Profit Quality(5y)158.3%
High Growth Momentum
Growth
EPS 1Y (TTM)5.54%
EPS 3Y10.13%
EPS 5Y10.05%
EPS Q2Q%4.17%
EPS Next Y11.83%
EPS Next 2Y11.63%
EPS Next 3Y11.58%
EPS Next 5Y11.32%
Revenue 1Y (TTM)23.96%
Revenue growth 3Y12.39%
Revenue growth 5Y9.98%
Sales Q2Q%14.4%
Revenue Next Year5.37%
Revenue Next 2Y4.76%
Revenue Next 3Y5.08%
Revenue Next 5Y5.63%
EBIT growth 1Y3.16%
EBIT growth 3Y5.54%
EBIT growth 5Y1.75%
EBIT Next Year20.66%
EBIT Next 3Y8.58%
EBIT Next 5Y8.65%
FCF growth 1Y-41.3%
FCF growth 3Y14.05%
FCF growth 5Y1.21%
OCF growth 1Y-36.13%
OCF growth 3Y12.95%
OCF growth 5Y1.79%